Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184(2):101–22. ex 1.
Reiber H. Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry. Arq Neuropsiquiatr. 2016;74(6):501–12.
Article
Google Scholar
Reiber H. Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry. Arq Neuropsiquiatr. 2016;74(4):337–50.
Article
Google Scholar
Ursula K. Rohlwink, Katya Mauff, Katalin A. Wilkinson, Nico Enslin, Emmanuel Wegoye,Robert J. Wilkinson, and Anthony A. Figaji. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis. Clin Infect Dis 2017:65:1298–307
Ursula K. Rohlwink, Katya Mauff, and Anthony Figaji. Correspondence. Clin Infect Dis 2018;67(4):642–3
Article
Google Scholar
Bu X-L, Yao X-Q, Jiao S-S, Zeng F, Liu Y-H, Xiang Y., Liang C-R, Wang Q-H, Wang X., Cao H-Y et al. A study on the association between infectious burden and Alzheimer’s disease. Eur J Neurol. 2015;22(12):1519–25.
Article
Google Scholar
Harris SA, Harris EA. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic lzheimer’s Disease. J Alzheimers Dis. 2015;48(2):319–53
Article
CAS
Google Scholar
Tejera D, Mercan D, Sanchez-Caro JM, et al. Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome. EMBO J. 2019;38(17):e101064.
Article
Google Scholar
Lövheim H, Gilthorpe J, Johansson A, Eriksson S, Hallmans G, Alzheimers FE. Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study. Dement. 2015; 11(6): 587–592. Published online 2014 Oct 7
Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. 2009 - J Pathol Volume217, Issue1 January 2009 Pages 131–138
Itzhaki RF et al. The role of Viruses and of APOE in Dementia. Ann. N.Y. Acad. Sci. 1019: 15–18 (2004).
Article
CAS
Google Scholar
Fülöp T, Itzhaki RF, Balin BJ, Miklossy J, Barron AE. Role of Microbes in the Development of Alzheimer’s Disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco. Front Genet. 2018;9:362.
Zhan X, Stamova B, Jin LW, DeCarli C, Phinney B, Sharp FR. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology. 2016;87:2324–32.
Article
CAS
Google Scholar
Cabral CM, McGovern KE, MacDonald WR, Franco J, Koshy AA. Dissecting Amyloid Beta Deposition Using Distinct Strains of the Neurotropic Parasite Toxoplasma gondii as a Novel Tool. ASN Neuro. 2017;9(4):1759091417724915.
Article
Google Scholar
Kumar DKV, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med. 2016;8(340):340ra72.
Article
Google Scholar
Hogestyn JM, Mock DJ, Mayer-Proschel M. Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. Neural Regeneration Research. 2018;13(2):211–221.
Article
Google Scholar
Sochocka M, Zwolińska K, Leszek J. The Infectious Etiology of Alzheimer’s Disease. Curr Neuropharmacol. 2017;15:996–1009.
Article
CAS
Google Scholar
Itzhaki, R.F., Golde, T.E., Heneka, M.T. et al. Do infections have a role in the pathogenesis of Alzheimer disease?. Nat Rev Neurol 16:193–197 (2020). https://doi.org/10.1038/s41582-020-0323-9
Article
PubMed
Google Scholar
Di Stefano A, Alcantarini C, Atzori C, Lipani F, Imperiale D, Burdino E, Audagnotto S, Mighetto L, Milia MG, Di Perri G, Calcagno A. Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study. CNS Spectr. 2019:1–7.
Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133–150.
Article
CAS
Google Scholar
Shimada T, Fournier AE, Yamagata K. Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int. 2013;2013:564534
Article
Google Scholar
Wang J, Ben J. A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain. Nat Rev Neurol. 2017;13(11):703
Article
Google Scholar
Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G. Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction. Int J Mol Sci. 2014;15(3):4671–713.
Soscia SJ, Kirby J, Washicosky K, et al. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010;5(3):e9505.
Moir RD, Vijaya Kumar D, Choi S, Tanzi RE. The emerging antimicrobial protection hypothesis of Alzheimer’s disease. Innov Aging. 2017;1(Suppl 1):1152.
Article
Google Scholar
Gosztyla ML, Brothers HM, Robinson SR. Alzheimer’s Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence. J Alzheimers Dis. 2018;62(4):1495–1506. https://doi.org/10.3233/JAD-171133. PMID: 29504537.
Bloom GS. Amyloid-β and Tau: The Trigger and Bullet in Alzheimer Disease Pathogenesis. JAMA Neurol. 2014;71(4):505–8.
Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, et al. Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection [published correction appears in Neuron. 2018 Dec 19;100(6):1527–1532]. Neuron. 2018;99(1):56–63.e3.
Magnus S, Magnus G et al. Low cerebrospinal fluid b-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci lett. 2001;314(1–2):33–6.
Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ. Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging. 2004;25:619–27.
Itzhaki, RF et al. Microbes and Alzheimer’s Disease. J Alzheimer’s Dis. 2016;51(4);979–84.
Article
Google Scholar
Duarte LF, Farías MA, Álvarez DM, et al. Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders. Front Cell Neurosci. 2019;13:46. https://doi.org/10.3389/fncel.2019.00046.
Karine Bourgadea, Gilles Dupuis et al. Anti-Viral Properties of Amyloid- Peptides. J Alzheimer’s Disease 54 (2016) 859–878.
Article
Google Scholar
Sperling RA, Donohue MC, Raman R, et al. A4 Study Team. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals. JAMA Neurol. 2020;77(6):735–45. https://doi.org/10.1001/jamaneurol.2020.0387.
Shen CH, Chou CH, Liu FC, et al. Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore). 2016;95(8):e2883. https://doi.org/10.1097/MD.0000000000002883.
Nakamura A, Kaneko N, Villemagne VL, et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature. 2018;554(7691):249–254. https://doi.org/10.1038/nature25456. Epub 2018 Jan 31.
Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol. 2016; 15(7): 673–684.
Article
CAS
Google Scholar
Palmqvist S, Janelidze S, Stomrud E, et al. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status [published online ahead of print, 2019 Jun 24]. JAMA Neurol. 2019;e191632.
Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest. 2017;127(9):3210–3219.
Article
Google Scholar
Abbott NJ, Pizzo, ME, Preston, JE et al. The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system? Acta Neuropathol (2018) 135: 387
Article
CAS
Google Scholar